We are live on
!
Find out more
BCM
Brookmont Capital Management Portfolio holdings
AUM
$186M
1-Year Est. Return
10.11%
This Fund
S&P 500
This Quarter
Est. Return
+6.13%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$165M
AUM Growth
+$10.1M
(+6.5%)
Cap. Flow
+$1.03M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
55.04%
Holding
57
New
4
Increased
28
Reduced
21
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$1.38M |
| 2 |
Honeywell
HON
|
+$1.13M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$214K |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$204K |
| 5 |
NVIDIA
NVDA
|
+$199K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$2.15M |
| 2 |
Lowe's Companies
LOW
|
+$215K |
| 3 |
Wells Fargo
WFC
|
+$25K |
| 4 |
JPMorgan Chase
JPM
|
+$22.6K |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$20.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.14% |
| 2 | Financials | 13.2% |
| 3 | Healthcare | 9.31% |
| 4 | Technology | 8.92% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $214K | 0.13% |
+2,600
| New | +$214K |
|
52
UnitedHealth
UNH
$369B
| $209K | 0.13% |
522
-35
| -6% | -$14K |
|
53
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $206K | 0.12% |
420
| – | – |
|
|
54
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $205K | 0.12% |
+2,279
| New | +$204K |
|
55
Apple
AAPL
$4.58T
| $201K | 0.12% |
+1,469
| New | +$190K |
|
|
56
Lowe's Companies
LOW
$125B
| – | – |
-1,132
| Closed | -$215K |
|
|
57
Novartis
NVS
$297B
| – | – |
-25,206
| Closed | -$2.15M |
|
Similar funds
CC
BGA
OBC
HC
WWM
RCM
BAM
SVBP
Brookmont Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Brookmont Capital Management held 57 positions worth $165M, up 6.5% from $155M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Brookmont Capital Management's Q2 2021 filing shows 4 new, 28 increased, 21 reduced and 2 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 2,600 shares worth $214K. The largest sale was Novartis, an estimated $2.15M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- Brookmont Capital Management's largest Q2 2021 buy was Vanguard Short-Term Bond ETF: 2,600 shares worth $214K.
- Brookmont Capital Management added most to Paramount Global Class B in Q2 2021, an estimated $1.38M increase.
- Brookmont Capital Management's biggest Q2 2021 reduction was Wells Fargo, cutting an estimated $25K.
- Brookmont Capital Management fully exited Novartis in Q2 2021, selling an estimated $2.15M.
- Brookmont Capital Management's ten largest holdings make up 55% of its $165M portfolio in Q2 2021.
- Brookmont Capital Management opened 4 new positions and closed 2 in Q2 2021.
- Brookmont Capital Management's portfolio value rose 6.5% quarter-over-quarter to $165M.
Based on Brookmont Capital Management's 13F filing for Q2 2021, filed 19 Jul 2021.